We’re excited to announce our participation in the ASCA * SAMBA 2026 Conference and Expo, taking place May 13-16 in Washington, DC.
We look forward to connecting with fellow professionals and showcasing how the HemoCue® Glucose Systems offer ideal solutions for ASCs, supporting surgical readiness, lowering infection risks, and maintaining regulatory compliance.
HemoCue will also present a complementary continuing education (CE) program covering glucose testing systems, compliance, and best practices for infection control in ambulatory settings. With proper training and adherence to guidelines, healthcare providers can ensure accurate, safe testing and better outcomes for patients.
Visit HemoCue at booth #1122
